Diabetics may do marginally better with drug-eluting stents

NEW YORK (Reuters Health) - After primary coronary angioplasty, diabetics have lower rates of target vessel revascularization if they received drug-eluting stents (DES) rather than bare metal stents (BMS), a new paper says.
Source: Modern Medicine - Category: Journals (General) Source Type: news